The MNNG-HOS transforming gene (MET) encoding the receptor tyrosine kinase for hepatocyte growth factor (HGF) is involved in cancer progression and metastasis formation, and suggests poor prognosis in early stage and second-line HCC patients [6-8]. The gene discussed is HGF; the disease is hepatocellular carcinoma.